期刊文献+

人黑色素瘤抗原MAGE-A10的基因克隆及原核表达 被引量:1

Cloning and expression of human melanoma antigen MAGE-A10
下载PDF
导出
摘要 目的 :扩增和克隆人黑色素瘤抗原MAGE A1 0(melanomaantigenA1 0 )cDNA ,构建原核表达载体并在大肠杆菌表达 .方法 :从人黑色素瘤细胞系LiBr中提取总RNA ,用RT PCR从中扩增出MAGE A1 0cDNA ,插入载体pMD1 8 T中 .测序正确后 ,克隆至原核表达载体pGEX 4T 3中 ,构建重组表达载体pGEX 4T 3 MAGE A1 0 ,转化大肠杆菌BL2 1株进行表达 .经IPTG诱导表达 ,谷胱甘肽亲和层析获得重组目的蛋白 .结果 :成功获得MAGE A1 0编码基因并构建原核表达载体 ,测序结果与GenBank收录序列相一致 .可以获得部分可溶性的原核重组蛋白 ,经亲和层析和分析 ,证实融合蛋白占总量的 5 8.9% .SDS PAGE分析其相对分子质量 (Mr)为 6 70 0 0 ,Westernblot证实为目的蛋白 .结论 :成功获得MAGE A1 0cDNA ,构建得原核表达载体并获得高效表达 .本研究为制备MAGE A1 0mAb及研究MAGE A1 0可能参与肿瘤发生发展的机制奠定了基础 . AIM: To clone human MAGE A10 cDNA and to express its recombinant protein in E. coli . METHODS: The cDNA encoding human MAGE A10 gene was amplified by RT PCR from human melanoma cell line LiBr before the MAGE A10 gene was inserted into plasmids pMD18 T. After sequencing, the MAGE A10 was cloned into the prokaryotic expression vector pGEX 4T 3 to construct the recombinant expression vector pGEX 4T 3 MAGE A10 and was transformed into E. coli BL21. The recombinant GST MAGE A10 fusion protein was expressed under induction of IPTG and GST MAGE fusion protein was purified through glutathione agarose column. RESULTS: The sequence of MAGE A10 was identical to the sequence from GenBank. By affinity column and SDS PAGE, the purified GST MAGE A10 fusion protein displayed a band of M r 67 000 , and the antigenic specificity of the fusion protein was confirmed by Western blot. CONCLUSION: The MAGE A10 gene has been successfully cloned and expressed, which not only provides the immunogen for the preparation of anti MAGE A10 antibody but also is useful in further research on the mechanism of tumor pathogenesis and cellular immunological response to MAGE molecules.
出处 《第四军医大学学报》 北大核心 2004年第9期805-807,共3页 Journal of the Fourth Military Medical University
基金 国际合作项目<单克隆抗体研究计划>
关键词 黑色素瘤抗原 逆转录-聚合酶链反应 基因克隆 基因表达 melanoma antigen RT-PCR gene cloning gene expression
  • 相关文献

参考文献8

  • 1Zendman AJ, Ruiter DJ, van Muijen GN. Cancer/testis-associated genes: Identification, expression profile, and putative function [J]. J Cell Physiol, 2003;194(3):272-288.
  • 2Rimoldi D, Salvi S, Reed D, et al. cDNA and protein characterization of human MAGE-A10 [J]. Int J Cancer, 1999;82(6):901-907.
  • 3Gillespie AM, Coleman RE. The potential of melanoma antigen expression in cancer therapy [J]. Cancer Treat Rev, 1999;25(4):219-227.
  • 4van Pel A, De Plaen E, Duffour MT, et al. Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes [J]. Cancer Immunol Immunother, 2001;49(11):593-602.
  • 5Brossart P. Dendritic cells in vaccination therapies of malignant diseases [J]. Transfus Apheresis Sci, 2002;27(2):183-186.
  • 6Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients meated with a peptide encoded by gene MAGE-3 and presented by HLA-A1 [J]. Int J Cancer, 1995; 63(6): 883-885.
  • 7Marchand.M, van Baren N, Weynants P, et al. Tumor regression observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 [J]. Int J Cancer, 1999;80(2):219-230.
  • 8Duffour MT, Chaux P, Lurquin C, et al. A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes[J]. Eur J Immunol, 1999;299(10):3329-3337.

同被引文献7

  • 1ELke J, Dirk J, Knuth Alexander. Clinical cancer vaccine trials[J]. Curr Opin Immunol, 2002,14(2): 178 - 182.
  • 2Scanlan MJ, Simpson A J, Old LJ. The cancer/testis genes: Review, standardization, and commentary[J]. Cancer Immunity,2002,4(1):1-15.
  • 3Chakraborty NG, Chattopadhyay S, Mehrotra S, et al. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma[J]. Hum Immunol, 2004,65(8):794 - 802.
  • 4Chi SN, Cheung NK, Cheung IY, et al. Expression of SSX-2 and SSX-4 genes in neuroblastoma[J]. Int J Biol Markers, 2002,17(4):219-223.
  • 5Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues[J]. Int J Cancer, 2001,92(6):856 - 860.
  • 6Jager E, Nagata Y, Gnjatic S, et al. Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses[J]. Proc Nail Acacl Sci USA, 2000, 97(7):4760 - 4765.
  • 7王彦刚,章翔,费舟,张剑宁,付洛安,刘卫平,赵爱志,郭庆东,刘先珍.基于RT-PCR基础上的体内重组法构建人源性胶质瘤单链抗体库[J].第四军医大学学报,2002,23(23):2175-2178. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部